Overview Nobivac Feline NXT FeLV is the first and only feline leukemia vaccine built on Merck Animal Health‘s RNA-particle technology platform. This groundbreaking innovation utilizes RNA particle technology to offer safe, robust, multi-layered protection without the need for adjuvants.

  • The vaccine‘s low volume of 0.5 ml and proven 2-year duration of immunity (DOI) ensure a comfortable experience for cats, addressing the need for effective protection against feline leukemia virus
  • Shown to be effective for vaccination of healthy cats 8 weeks of age or older against feline leukemia virus